Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Schrepf A, Lutgendorf SK, Pyter LM.

Brain Behav Immun. 2015 Oct;49:1-17. doi: 10.1016/j.bbi.2015.04.010. Review.

2.
3.

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.

Pitta Dda R, Sarian LO, Barreta A, Campos EA, Andrade LL, Fachini AM, Campbell LM, Derchain S.

BMC Cancer. 2013 Sep 18;13:423. doi: 10.1186/1471-2407-13-423.

4.

Experience of symptoms indicative of gynaecological cancers in UK women.

Low EL, Simon AE, Waller J, Wardle J, Menon U.

Br J Cancer. 2013 Aug 20;109(4):882-7. doi: 10.1038/bjc.2013.412.

5.

Symptoms and risk factors of ovarian cancer: a survey in primary care.

Gajjar K, Ogden G, Mujahid MI, Razvi K.

ISRN Obstet Gynecol. 2012;2012:754197. doi: 10.5402/2012/754197.

6.

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR.

Gynecol Oncol. 2012 Feb;124(2):230-5. doi: 10.1016/j.ygyno.2011.10.032.

7.

Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008.

Trivers KF, Rodriguez JL, Hawkins NA, Cooper CP, Polonec L, Gelb CA.

Prev Chronic Dis. 2011 Nov;8(6):A144.

8.

Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.

Woolery KT, Kruk PA.

Obstet Gynecol Int. 2011;2011:358493. doi: 10.1155/2011/358493.

9.

Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Lurie G, Wilkens LR, Thompson PJ, Matsuno RK, Carney ME, Goodman MT.

Gynecol Oncol. 2010 Nov;119(2):278-84. doi: 10.1016/j.ygyno.2010.05.028.

10.

Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.

Williams RM, Flesken-Nikitin A, Ellenson LH, Connolly DC, Hamilton TC, Nikitin AY, Zipfel WR.

Transl Oncol. 2010 Jun 1;3(3):181-94.

11.

Predictive value of symptoms for early detection of ovarian cancer.

Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS.

J Natl Cancer Inst. 2010 Feb 24;102(4):222-9. doi: 10.1093/jnci/djp500.

12.

A hospital-based case-control study of identifying ovarian cancer using symptom index.

Kim MK, Kim K, Kim SM, Kim JW, Park NH, Song YS, Kang SB.

J Gynecol Oncol. 2009 Dec;20(4):238-42. doi: 10.3802/jgo.2009.20.4.238.

13.

Risk of ovarian cancer in women with symptoms in primary care: population based case-control study.

Hamilton W, Peters TJ, Bankhead C, Sharp D.

BMJ. 2009 Aug 25;339:b2998. doi: 10.1136/bmj.b2998.

14.
15.

Prediagnostic symptoms of ovarian carcinoma: a case-control study.

Lurie G, Thompson PJ, McDuffie KE, Carney ME, Goodman MT.

Gynecol Oncol. 2009 Aug;114(2):231-6. doi: 10.1016/j.ygyno.2009.05.001.

16.

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Lowe KA, Andersen MR, Urban N, Paley P, Dresher CW, Goff BA.

Gynecol Oncol. 2009 Aug;114(2):225-30. doi: 10.1016/j.ygyno.2009.03.015.

17.

Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model.

Sheth RA, Upadhyay R, Stangenberg L, Sheth R, Weissleder R, Mahmood U.

Gynecol Oncol. 2009 Mar;112(3):616-22. doi: 10.1016/j.ygyno.2008.11.018.

18.

Identifying symptoms of ovarian cancer: a qualitative and quantitative study.

Bankhead CR, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, Mant D, Kehoe ST, Austoker J.

BJOG. 2008 Jul;115(8):1008-14. doi: 10.1111/j.1471-0528.2008.01772.x.

19.

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N.

Cancer. 2008 Aug 1;113(3):484-9. doi: 10.1002/cncr.23577.

Items per page

Supplemental Content

Support Center